New Content  edit
Get The App!

Loading the player...
How Do You Treat PV Patients That Fail Hydroxyurea (HU)?
Share URL
Embed Code
Share by Email
Send to social websites
Report this video as inappropriate You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email. Select your reason
Sexual Content Violent or Repulsive Content
Hateful or Abusive Content Harmful Dangerous Acts
Child Abuse Spam
Rubin Mesa MD, Serge Verstovsek MD, Richard Silver MD, and Emily Knight R.N., O.C.N. offer their perspectives and insights for optimal management of PV after hydroxyurea (HU) failure. HU is frequently used for first-line cytoreductive therapy in patients with PV, but some patients are poorly served, experiencing inadequate disease or symptom control, intolerable toxicity, or both, and may benefit from switching to a different therapy.